Is FormFactor (FORM) Still Overvalued After Recent Share Price Momentum Shift

What recent performance says about FormFactor stock

FormFactor (FORM) has drawn attention after a mixed stretch for the stock, with a gain of about 35% over the past 3 months but a decline of roughly 10% over the past month.

See our latest analysis for FormFactor.

That mix of a roughly 10% decline in the 1 month share price return, alongside a 35.36% 3 month share price return, suggests momentum has cooled recently. At the same time, the longer term trend, including a very large 1 year total shareholder return, remains strong.

If you are looking beyond FormFactor and want to see what else is moving around the semiconductor supply chain, it is worth scanning 46 AI infrastructure stocks

With FormFactor up very strongly over the past year but off its recent highs, and trading below the average analyst price target of about $145, the key question is whether there is still a buying opportunity here or whether the market is already pricing in future growth.

Most Popular Narrative: 26% Overvalued

FormFactor's most followed narrative puts fair value at about $101.56 per share, compared with the last close of $128. This frames the recent pullback in a very different light.

Accelerating adoption of generative AI, high-performance computing, and HBM DRAM in data centers is driving substantial increases in test complexity and intensity. FormFactor's differentiated probe cards and early leadership in HBM4 chiplet testing position the company to benefit from higher ASPs and revenue growth as these markets scale. (Impacts: Revenue, potential margin improvement)

Read the complete narrative.

Curious what kind of revenue path, profit margin shift, and future earnings multiple are embedded in that fair value estimate, and how tightly analysts are clustering around those assumptions.

Result: Fair Value of $101.56 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, rising tariffs that trim gross margins and any slowdown or misstep in advanced packaging or HBM test demand could quickly challenge that upbeat fair value story.

Find out about the key risks to this FormFactor narrative.

Next Steps

With such a mixed sentiment around risk and reward for FormFactor, it makes sense to move quickly and test the numbers yourself before forming a view. You might start with the balance of 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

If you stop with just one stock, you could miss out on opportunities that fit your goals even better, so broaden your watchlist with a few focused screens.

• Target potential bargains by scanning 53 high quality undervalued stocks that pair solid fundamentals with what may be appealing prices.
• Build a steadier income stream by reviewing 10 dividend fortresses that prioritize yield alongside financial strength.
• Protect your downside by filtering for 66 resilient stocks with low risk scores that score well on resilience and balance sheet quality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com